There is also a striking difference in vitro in the behaviour of T cell clones derived from tumour-infiltrating lymphocytes in that only CD5-negative clones are activated by tumour cells expressing low levels of cognate MHC/peptide complexes[14]. Here, HLA-C is linked to neoplasm.